We are live on
!
Find out more
TCMG
TSP Capital Management Group Portfolio holdings
AUM
$418M
1-Year Est. Return
68.45%
This Fund
S&P 500
This Quarter
Est. Return
-2.64%
1 Year Est. Return
+68.45%
3 Year Est. Return
+177.76%
5 Year Est. Return
+247.33%
10 Year Est. Return
+1,387.97%
AUM
$218M
AUM Growth
-$12.2M
(-5.3%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-105.7%
Top 10 Holdings %
Top 10 Hldgs %
40.6%
Holding
76
New
–
Increased
–
Reduced
–
Closed
74
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celldex Therapeutics
CLDX
|
+$11.8M |
| 2 |
SE
Spectra Energy Corp Wi
SE
|
+$11.3M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$11M |
| 4 |
Comcast
CMCSA
|
+$9.59M |
| 5 |
Xylem
XYL
|
+$8.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.18% |
| 2 | Materials | 14.56% |
| 3 | Communication Services | 12.88% |
| 4 | Industrials | 9.3% |
| 5 | Utilities | 7.42% |
Similar funds
FFA
WPI
TI
VIS
MCM
PA
PIMC
DBRC
TSP Capital Management Group's Q3 2014 Portfolio in Review
As of Q3 2014, TSP Capital Management Group held 76 positions worth $218M, down 5.3% from $230M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
TSP Capital Management Group withdrew a net $231M in Q3 2014, closing 74 positions. Its most notable exit was Celldex Therapeutics, an estimated $11.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Materials and Communication Services.
- TSP Capital Management Group fully exited Celldex Therapeutics in Q3 2014, selling an estimated $11.8M.
- TSP Capital Management Group's ten largest holdings make up 41% of its $218M portfolio in Q3 2014.
- TSP Capital Management Group opened 0 new positions and closed 74 in Q3 2014.
- TSP Capital Management Group's portfolio value fell 5.3% quarter-over-quarter to $218M.
Based on TSP Capital Management Group's 13F filing for Q3 2014, filed 10 Nov 2014.